Impact of genetic polymorphisms of leptin and TNF-α on rosiglitazone response in Chinese patients with type 2 diabetes

Author： Liu Hai-Ling   Lin Yang-Gen   Wu Jing   Sun Hong   Gong Zhi-Cheng   Hu Ping-Cheng   Yin Ji-Ye   Zhang Wei   Wang Dan   Zhou Hong-Hao   Liu Zhao-Qian  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.64, Iss.7, 2008-07, pp. : 663-671

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

TNF-α -857 and -1031 polymorphisms predict good therapeutic response to TNF-α blockers in Chinese Han patients with ankylosing spondylitis

By Tong Qiang   Zhao Dong-Bao   Bajracharya Punam   Xu Xia   Kong Rui-Na   Zhang Ju   Dai Sheng-Ming   Cai Qing  

Pharmacogenomics, Vol. 13, Iss. 13, 2012-10 ,pp. : 1459-1467

Future Medicine

Access to resources Recommend Favorite

Retrospective Analysis of Rosiglitazone and Macular Oedema in Patients with Type 2 Diabetes Mellitus

By Tatti Patrizio  

Clinical Drug Investigation, Vol. 28, Iss. 5, 2008-01 ,pp. : 327-332

Adis International

Access to resources Recommend Favorite

Addition of rosiglitazone is effective in patients with type 2 diabetes that is inadequately controlled

By  

Inpharma, Vol. 1, Iss. 1349, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Adjunctive rosiglitazone significantly improves glycaemic control in patients with type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids

By Kirchheiner Julia   Meineke Ingolf   Fuhr Uwe   Rodrííguez-Antona Cristina   Lebedeva Elena   Brockmööller Jüürgen  

Pharmacogenomics, Vol. 9, Iss. 3, 2008-03 ,pp. : 277-288

Future Medicine

Access to resources Recommend Favorite